| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.832 | 0.003 | 0.832 | 5 Hydroxytryptamine release stimulant | 0.716 0.006 CID_59215182 | ||
| 0.588 | 0.005 | 0.588 | 5 Hydroxytryptamine 2 antagonist | 0.268 0.019 CID_59215182 | ||
| 0.574 | 0.004 | 0.574 | 5 Hydroxytryptamine uptake inhibitor | 0.519 0.004 CID_59215182 | ||
| 0.539 | 0.01 | 0.539 | Anticonvulsant | 0.345 0.03 CID_59215182 | ||
| 0.511 | 0.005 | 0.511 | 5 Hydroxytryptamine 2A antagonist | 0.168 0.024 CID_59215182 | ||
| 0.518 | 0.034 | 0.611 | Antiobesity | 0.611 0.019 CID_59215182 | CID_59215182 | |
| 0.441 | 0.003 | 0.441 | Dopamine uptake inhibitor | 0.366 0.004 CID_59215182 | ||
| 0.489 | 0.064 | 0.489 | Caspase 9 stimulant | 0.397 0.113 CID_59215182 | ||
| 0.405 | 0.027 | 0.405 | HERG channel blocker | 0.333 0.041 CID_59215182 | ||
| 0.385 | 0.012 | 0.385 | 5 Hydroxytryptamine antagonist | 0.134 0.057 CID_59215182 | ||
| 0.366 | 0.004 | 0.366 | Adrenaline uptake inhibitor | 0.356 0.004 CID_59215182 | ||
| 0.336 | 0.011 | 0.336 | Acetylcholine antagonist | 0.278 0.016 CID_59215182 | ||
| 0.356 | 0.035 | 0.356 | Potassium channel (Voltage-sensitive) blocker | 0.301 0.049 CID_59215182 | ||
| 0.332 | 0.012 | 0.332 | Cholinergic antagonist | 0.279 0.017 CID_59215182 | ||
| 0.299 | 0.019 | 0.299 | Cholinergic | 0.22 0.038 CID_59215182 | ||
| 0.288 | 0.016 | 0.346 | Antipruritic | 0.346 0.009 CID_59215182 | CID_59215182 | |
| 0.279 | 0.009 | 0.279 | Alpha 2 adrenoreceptor antagonist | 0.129 0.034 CID_59215182 | ||
| 0.308 | 0.041 | 0.464 | 5 Hydroxytryptamine uptake stimulant | 0.464 0.006 CID_59215182 | CID_59215182 | |
| 0.281 | 0.017 | 0.281 | Alpha adrenoreceptor antagonist | 0.127 0.045 CID_59215182 | ||
| 0.271 | 0.013 | 0.271 | Calcium channel blocker | 0.178 0.04 CID_59215182 | ||
| 0.261 | 0.004 | 0.278 | Myeloperoxidase inhibitor | 0.278 0.004 CID_59215182 | CID_59215182 | |
| 0.258 | 0.01 | 0.258 | 5 Hydroxytryptamine agonist | 0.203 0.014 CID_59215182 | ||
| 0.264 | 0.017 | 0.264 | 5 Hydroxytryptamine 2B antagonist | 0.218 0.023 CID_59215182 | ||
| 0.241 | 0.004 | 0.247 | 5 Hydroxytryptamine 2A agonist | 0.247 0.004 CID_59215182 | CID_59215182 | |
| 0.257 | 0.023 | 0.257 | Acetylcholine M1 receptor antagonist | 0.23 0.031 CID_59215182 | ||
| 0.237 | 0.004 | 0.266 | 5 Hydroxytryptamine 2C agonist | 0.266 0.004 CID_59215182 | CID_59215182 | |
| 0.243 | 0.015 | 0.243 | Acetylcholine muscarinic antagonist | 0.203 0.024 CID_59215182 | ||
| 0.243 | 0.019 | 0.243 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.227 | 0.004 | 0.236 | 5 Hydroxytryptamine 2 agonist | 0.236 0.004 CID_59215182 | CID_59215182 | |
| 0.225 | 0.004 | 0.234 | Dopamine transporter inhibitor | 0.234 0.004 CID_59215182 | CID_59215182 | |
| 0.233 | 0.016 | 0.233 | Dopamine antagonist | 0.113 0.034 CID_59215182 | ||
| 0.235 | 0.019 | 0.235 | Sodium channel (voltage-gated) blocker | 0.195 0.032 CID_59215182 | ||
| 0.293 | 0.078 | 0.37 | Nootropic | 0.37 0.047 CID_59215182 | CID_59215182 | |
| 0.267 | 0.056 | 0.267 | 5 Hydroxytryptamine 1E antagonist | 0.237 0.089 CID_59215182 | ||
| 0.217 | 0.015 | 0.217 | Dopamine D2 antagonist | 0.095 0.034 CID_59215182 | ||
| 0.213 | 0.012 | 0.213 | Alpha 2a adrenoreceptor antagonist | 0.16 0.02 CID_59215182 | ||
| 0.204 | 0.006 | 0.204 | Acetylcholine M4 receptor antagonist | 0.094 0.034 CID_59215182 | ||
| 0.279 | 0.09 | 0.279 | Caspase 3 stimulant | |||
| 0.193 | 0.015 | 0.193 | 5 Hydroxytryptamine 1A antagonist | 0.067 0.047 CID_59215182 | ||
| 0.186 | 0.01 | 0.186 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CID_59215182 | ||
| 0.177 | 0.003 | 0.187 | 5 Hydroxytryptamine 2B agonist | 0.187 0.003 CID_59215182 | CID_59215182 | |
| 0.178 | 0.005 | 0.178 | Nicotinic alpha4beta2 receptor antagonist | 0.164 0.006 CID_59215182 | ||
| 0.182 | 0.01 | 0.182 | Acetylcholine nicotinic agonist | 0.165 0.013 CID_59215182 | ||
| 0.192 | 0.022 | 0.192 | Alpha 1 adrenoreceptor antagonist | 0.093 0.046 CID_59215182 | ||
| 0.183 | 0.018 | 0.183 | 5 Hydroxytryptamine 1 antagonist | 0.067 0.056 CID_59215182 | ||
| 0.172 | 0.012 | 0.172 | CDC-like kinase 3 inhibitor | |||
| 0.186 | 0.027 | 0.186 | Alpha 2b adrenoreceptor antagonist | 0.095 0.08 CID_59215182 | ||
| 0.177 | 0.019 | 0.177 | Acetylcholine agonist | 0.169 0.021 CID_59215182 | ||
| 0.193 | 0.035 | 0.193 | Sodium channel blocker | 0.165 0.048 CID_59215182 | ||
| 0.163 | 0.006 | 0.163 | Acetylcholine M5 receptor antagonist | 0.121 0.012 CID_59215182 | ||
| 0.191 | 0.041 | 0.191 | CDC-like kinase 1 inhibitor | |||
| 0.171 | 0.02 | 0.171 | Alpha 1a adrenoreceptor antagonist | 0.082 0.044 CID_59215182 | ||
| 0.219 | 0.07 | 0.219 | Psychostimulant | 0.141 0.125 CID_59215182 | ||
| 0.152 | 0.006 | 0.152 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.187 | 0.045 | 0.187 | MAO inhibitor | 0.122 0.073 CID_59215182 | ||
| 0.162 | 0.027 | 0.162 | Alpha 2c adrenoreceptor antagonist | |||
| 0.143 | 0.011 | 0.143 | Calcium channel L-type blocker | 0.091 0.03 CID_59215182 | ||
| 0.146 | 0.015 | 0.146 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.141 | 0.012 | 0.141 | Acetylcholine M3 receptor antagonist | 0.131 0.013 CID_59215182 | ||
| 0.2 | 0.076 | 0.2 | Neurotrophic factor enhancer | 0.189 0.088 CID_59215182 | ||
| 0.253 | 0.132 | 0.253 | Vasodilator, coronary | 0.198 0.184 CID_59215182 | ||
| 0.125 | 0.004 | 0.13 | Purinergic P2X4 antagonist | 0.13 0.004 CID_59215182 | CID_59215182 | |
| 0.144 | 0.024 | 0.144 | Calcium antagonist | |||
| 0.143 | 0.026 | 0.143 | Nitric-oxide synthase inhibitor | 0.086 0.085 CID_59215182 | ||
| 0.16 | 0.046 | 0.195 | Sphingosine 1-phosphate receptor 5 antagonist | 0.195 0.014 CID_59215182 | CID_59215182 | |
| 0.159 | 0.045 | 0.159 | Topoisomerase II inhibitor | |||
| 0.137 | 0.024 | 0.137 | Acetylcholine nicotinic antagonist | 0.133 0.026 CID_59215182 | ||
| 0.211 | 0.099 | 0.281 | Tumour necrosis factor alpha release inhibitor | 0.281 0.061 CID_59215182 | CID_59215182 | |
| 0.126 | 0.016 | 0.126 | Neuronal nicotinic receptor antagonist | 0.123 0.017 CID_59215182 | ||
| 0.13 | 0.02 | 0.13 | Dopamine D4 antagonist | 0.065 0.039 CID_59215182 | ||
| 0.146 | 0.038 | 0.146 | MAO B inhibitor | 0.086 0.069 CID_59215182 | ||
| 0.143 | 0.041 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.109 | 0.011 | 0.109 | Nicotinic neuronal receptor agonist | 0.08 0.021 CID_59215182 | ||
| 0.177 | 0.082 | 0.177 | P-glycoprotein inhibitor | 0.16 0.102 CID_59215182 | ||
| 0.108 | 0.02 | 0.108 | Nav1.7 sodium channel blocker | 0.082 0.032 CID_59215182 | ||
| 0.116 | 0.029 | 0.116 | Phosphodiesterase 6D inhibitor | 0.091 0.072 CID_59215182 | ||
| 0.095 | 0.009 | 0.095 | Nicotinic alpha3beta2 receptor antagonist | 0.084 0.012 CID_59215182 | ||
| 0.26 | 0.174 | 0.385 | Analgesic | 0.385 0.091 CID_59215182 | CID_59215182 | |
| 0.172 | 0.087 | 0.172 | Hepatoprotectant | |||
| 0.095 | 0.01 | 0.096 | Nicotinic receptor alpha3 subunit antagonist | 0.096 0.01 CID_59215182 | CID_59215182 | |
| 0.096 | 0.014 | 0.096 | I kappa B kinase 2 inhibitor | 0.069 0.034 CID_59215182 | ||
| 0.13 | 0.05 | 0.13 | Topoisomerase I inhibitor | |||
| 0.128 | 0.048 | 0.128 | Calcium channel (voltage-sensitive) blocker | 0.094 0.093 CID_59215182 | ||
| 0.102 | 0.024 | 0.129 | Dopamine D1 antagonist | 0.129 0.018 CID_59215182 | CID_59215182 | |
| 0.182 | 0.105 | 0.182 | Potassium channel blocker | 0.151 0.134 CID_59215182 | ||
| 0.139 | 0.063 | 0.139 | Acetylcholinesterase inhibitor | |||
| 0.172 | 0.098 | 0.204 | I kappa B kinase epsilon inhibitor | 0.204 0.067 CID_59215182 | CID_59215182 | |
| 0.119 | 0.046 | 0.119 | DOPA decarboxylase inhibitor | 0.113 0.054 CID_59215182 | ||
| 0.11 | 0.039 | 0.11 | Acetylcholine M3 receptor agonist | 0.085 0.056 CID_59215182 | ||
| 0.105 | 0.035 | 0.105 | I kappa B kinase inhibitor | 0.083 0.057 CID_59215182 | ||
| 0.115 | 0.047 | 0.115 | Antiadrenergic | 0.096 0.059 CID_59215182 | ||
| 0.113 | 0.047 | 0.113 | Adrenaline antagonist | 0.093 0.058 CID_59215182 | ||
| 0.079 | 0.013 | 0.08 | Nicotinic receptor alpha4 subunit antagonist | 0.08 0.013 CID_59215182 | CID_59215182 | |
| 0.086 | 0.026 | 0.086 | Acetylcholine M2 receptor antagonist | |||
| 0.216 | 0.158 | 0.277 | Vasodilator, peripheral | 0.277 0.109 CID_59215182 | CID_59215182 | |
| 0.078 | 0.025 | 0.078 | 5 Hydroxytryptamine 5A antagonist | 0.059 0.047 CID_59215182 | ||
| 0.07 | 0.019 | 0.07 | Acetylcholine M2 receptor agonist | 0.069 0.02 CID_59215182 | ||
| 0.078 | 0.028 | 0.078 | 5 Hydroxytryptamine 3 agonist | |||
| 0.106 | 0.06 | 0.106 | MAO A inhibitor | 0.089 0.072 CID_59215182 | ||
| 0.05 | 0.005 | 0.05 | Nicotinic alpha4beta2 receptor agonist | 0.05 0.005 CID_59215182 | ||
| 0.08 | 0.035 | 0.08 | Acetylcholine M5 receptor agonist | |||
| 0.098 | 0.053 | 0.103 | Toll-Like receptor 3 antagonist | 0.103 0.046 CID_59215182 | CID_59215182 | |
| 0.074 | 0.029 | 0.074 | Protease activated receptor antagonist | |||
| 0.113 | 0.068 | 0.113 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.14 | 0.097 | 0.153 | Melanin inhibitor | 0.153 0.077 CID_59215182 | CID_59215182 | |
| 0.136 | 0.094 | 0.136 | MAP kinase kinase 4 inhibitor | 0.127 0.123 CID_59215182 | ||
| 0.11 | 0.068 | 0.156 | Nav1.5 sodium channel blocker | 0.156 0.024 CID_59215182 | CID_59215182 | |
| 0.065 | 0.027 | 0.065 | Nicotinic alpha7 receptor agonist | |||
| 0.074 | 0.035 | 0.074 | Dopamine D3 antagonist | |||
| 0.067 | 0.029 | 0.067 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.075 | 0.04 | 0.113 | Dopamine agonist | 0.113 0.022 CID_59215182 | CID_59215182 | |
| 0.08 | 0.046 | 0.08 | Alpha 1b adrenoreceptor antagonist | |||
| 0.06 | 0.028 | 0.167 | Lysine-specific demethylase 1A inhibitor | 0.167 0.004 CID_59215182 | CID_59215182 | |
| 0.051 | 0.019 | 0.051 | GABA B receptor antagonist | 0.044 0.028 CID_59215182 | ||
| 0.071 | 0.04 | 0.071 | Glutamate (mGluR7) antagonist | |||
| 0.088 | 0.057 | 0.088 | Antineoplastic alkaloid | |||
| 0.06 | 0.029 | 0.06 | Nicotinic receptor alpha7 subunit antagonist | 0.056 0.034 CID_59215182 | ||
| 0.083 | 0.054 | 0.083 | Phosphodiesterase 11A inhibitor | |||
| 0.083 | 0.054 | 0.083 | Phosphodiesterase XI inhibitor | |||
| 0.108 | 0.08 | 0.126 | Interleukin 8 antagonist | 0.126 0.054 CID_59215182 | CID_59215182 | |
| 0.072 | 0.045 | 0.072 | Toll-Like receptor 7 antagonist | 0.065 0.051 CID_59215182 | ||
| 0.04 | 0.013 | 0.04 | Endothelin receptor antagonist | |||
| 0.045 | 0.02 | 0.045 | GABA uptake inhibitor | 0.043 0.023 CID_59215182 | ||
| 0.179 | 0.154 | 0.183 | DNA synthesis inhibitor | 0.183 0.148 CID_59215182 | CID_59215182 | |
| 0.033 | 0.008 | 0.033 | Endothelin B receptor antagonist | |||
| 0.139 | 0.114 | 0.156 | Tumour necrosis factor antagonist | 0.156 0.093 CID_59215182 | CID_59215182 | |
| 0.031 | 0.006 | 0.031 | Imidazoline I1 receptor antagonist | |||
| 0.083 | 0.059 | 0.09 | 5 Hydroxytryptamine 2C antagonist | 0.09 0.052 CID_59215182 | CID_59215182 | |
| 0.126 | 0.104 | 0.246 | NOS3 expression enhancer | 0.246 0.027 CID_59215182 | CID_59215182 | |
| 0.067 | 0.052 | 0.077 | 5 Hydroxytryptamine 1F antagonist | 0.077 0.045 CID_59215182 | CID_59215182 | |
| 0.07 | 0.057 | 0.071 | MAP-kinase-activated kinase 2 inhibitor | 0.071 0.056 CID_59215182 | CID_59215182 | |
| 0.055 | 0.044 | 0.055 | Alpha 1d adrenoreceptor antagonist | |||
| 0.023 | 0.013 | 0.023 | Endothelin A receptor antagonist | |||
| 0.044 | 0.034 | 0.044 | Mannosidase inhibitor | |||
| 0.076 | 0.068 | 0.079 | MAP-kinase-activated kinase inhibitor | 0.079 0.063 CID_59215182 | CID_59215182 | |
| 0.065 | 0.057 | 0.065 | Phosphodiesterase V inhibitor | |||
| 0.147 | 0.139 | 0.147 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.017 | 0.01 | 0.023 | Nicotinic alpha4 receptor agonist | 0.023 0.005 CID_59215182 | CID_59215182 | |
| 0.123 | 0.117 | 0.136 | Neuropeptide Y1 antagonist | 0.136 0.088 CID_59215182 | CID_59215182 | |
| 0.235 | 0.23 | 0.411 | Cyclophilin D inhibitor | 0.411 0.085 CID_59215182 | CID_59215182 | |
| 0.039 | 0.033 | 0.055 | Dopamine D5 antagonist | 0.055 0.022 CID_59215182 | CID_59215182 | |
| 0.014 | 0.009 | 0.014 | Integrin beta6 antagonist | |||
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.076 | 0.072 | 0.076 | GABA A receptor agonist | |||
| 0.032 | 0.032 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 CID_59215182 | CID_59215182 | |
| 0.069 | 0.074 | 0.078 | GABA B receptor agonist | 0.078 0.046 CID_59215182 | CID_59215182 | |
| 0.044 | 0.051 | 0.049 | Sodium/calcium exchanger inhibitor | 0.049 0.037 CID_59215182 | CID_59215182 | |
| 0.088 | 0.094 | 0.102 | GABA receptor agonist | 0.102 0.075 CID_59215182 | CID_59215182 | |
| 0.077 | 0.086 | 0.086 | Check point kinase 2 inhibitor | 0.086 0.078 CID_59215182 | CID_59215182 | |
| 0.034 | 0.048 | 0.043 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.022 CID_59215182 | CID_59215182 | |
| 0.12 | 0.135 | 0.149 | Nitric oxide antagonist | 0.149 0.096 CID_59215182 | CID_59215182 | |
| 0.099 | 0.115 | 0.11 | NADPH oxidase inhibitor | 0.11 0.097 CID_59215182 | CID_59215182 | |
| 0.03 | 0.047 | 0.083 | Dopamine D5 agonist | 0.083 0.005 CID_59215182 | CID_59215182 | |
| 0.021 | 0.039 | 0.037 | Nicotinic alpha3beta4 receptor agonist | 0.037 0.013 CID_59215182 | CID_59215182 | |
| 0.026 | 0.056 | 0.035 | Somatostatin 4 agonist | 0.035 0.029 CID_59215182 | CID_59215182 | |
| 0.023 | 0.056 | 0.033 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.032 CID_59215182 | CID_59215182 | |
| 0.183 | 0.222 | 0.205 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.205 0.151 CID_59215182 | CID_59215182 | |
| 0.087 | 0.13 | 0.216 | Toll-Like receptor 2 antagonist | 0.216 0.017 CID_59215182 | CID_59215182 | |
| 0.051 | 0.101 | 0.08 | Phospholipase D inhibitor | 0.08 0.034 CID_59215182 | CID_59215182 | |
| 0.069 | 0.119 | 0.111 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 CID_59215182 | CID_59215182 | |
| 0.012 | 0.068 | 0.025 | Dopamine D1 agonist | 0.025 0.013 CID_59215182 | CID_59215182 | |
| 0.115 | 0.177 | 0.164 | Lipocortins synthesis antagonist | 0.164 0.087 CID_59215182 | CID_59215182 | |
| 0.104 | 0.168 | 0.133 | Adenylate cyclase stimulant | 0.133 0.095 CID_59215182 | CID_59215182 | |
| 0.149 | 0.216 | 0.23 | Nitric-oxide synthase stimulant | 0.23 0.049 CID_59215182 | CID_59215182 | |
| 0.044 | 0.112 | 0.067 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.067 0.065 CID_59215182 | CID_59215182 | |
| 0.022 | 0.101 | 0.062 | NMDA receptor subunit 3B antagonist | 0.062 0.018 CID_59215182 | CID_59215182 | |
| 0.131 | 0.214 | 0.169 | Hypoglycemic | 0.169 0.149 CID_59215182 | CID_59215182 | |
| 0.097 | 0.182 | 0.136 | Hemostatic | 0.136 0.087 CID_59215182 | CID_59215182 | |
| 0.066 | 0.152 | 0.109 | AMP-activated protein kinase stimulant | 0.109 0.06 CID_59215182 | CID_59215182 | |
| 0.115 | 0.202 | 0.148 | Phospholipase C inhibitor | 0.148 0.109 CID_59215182 | CID_59215182 | |
| 0.145 | 0.232 | 0.206 | Transcription factor NF kappa B inhibitor | 0.206 0.163 CID_59215182 | CID_59215182 | |
| 0.036 | 0.129 | 0.076 | Beta adrenoreceptor antagonist | 0.076 0.03 CID_59215182 | CID_59215182 | |
| 0.092 | 0.187 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | 0.129 0.076 CID_59215182 | CID_59215182 | |
| 0.141 | 0.239 | 0.21 | Cholesterol antagonist | 0.21 0.156 CID_59215182 | CID_59215182 | |
| 0.06 | 0.158 | 0.101 | Estrogen receptor beta antagonist | 0.101 0.062 CID_59215182 | CID_59215182 | |
| 0.058 | 0.16 | 0.091 | 5 Hydroxytryptamine 3A agonist | 0.091 0.088 CID_59215182 | CID_59215182 | |
| 0.072 | 0.178 | 0.113 | Estrogen antagonist | 0.113 0.068 CID_59215182 | CID_59215182 | |
| 0.077 | 0.19 | 0.121 | Protein kinase stimulant | 0.121 0.091 CID_59215182 | CID_59215182 | |
| 0.164 | 0.277 | 0.315 | Calcium channel activator | 0.315 0.077 CID_59215182 | CID_59215182 | |
| 0.058 | 0.178 | 0.114 | Vascular endothelial growth factor 3 antagonist | 0.114 0.102 CID_59215182 | CID_59215182 | |
| 0.049 | 0.176 | 0.076 | Estrogen receptor alpha antagonist | 0.076 0.055 CID_59215182 | CID_59215182 | |
| 0.055 | 0.184 | 0.08 | Interleukin 5 antagonist | 0.08 0.072 CID_59215182 | CID_59215182 | |
| 0.025 | 0.159 | 0.061 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.036 CID_59215182 | CID_59215182 | |
| 0.055 | 0.189 | 0.095 | Adenylate cyclase inhibitor | 0.095 0.088 CID_59215182 | CID_59215182 | |
| 0.055 | 0.195 | 0.112 | Beta glucuronidase inhibitor | 0.112 0.055 CID_59215182 | CID_59215182 | |
| 0.024 | 0.172 | 0.051 | NMDA 2B receptor antagonist | 0.051 0.042 CID_59215182 | CID_59215182 | |
| 0.047 | 0.196 | 0.099 | GABA C receptor agonist | 0.099 0.067 CID_59215182 | CID_59215182 | |
| 0.028 | 0.178 | 0.077 | Sphingosine kinase inhibitor | 0.077 0.018 CID_59215182 | CID_59215182 | |
| 0.033 | 0.184 | 0.116 | NMDA receptor antagonist | 0.116 0.038 CID_59215182 | CID_59215182 | |
| 0.011 | 0.163 | 0.034 | NMDA receptor subunit 3A antagonist | 0.034 0.031 CID_59215182 | CID_59215182 | |
| 0.141 | 0.296 | 0.206 | Apoptosis antagonist | 0.206 0.171 CID_59215182 | CID_59215182 | |
| 0.025 | 0.195 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 CID_59215182 | CID_59215182 | |
| 0.017 | 0.191 | 0.049 | Sphingosine kinase 1 inhibitor | 0.049 0.018 CID_59215182 | CID_59215182 | |
| 0.039 | 0.234 | 0.163 | HIV-1 integrase (Overall Integration) inhibitor | 0.163 0.021 CID_59215182 | CID_59215182 | |
| 0.038 | 0.238 | 0.114 | Cholesterol synthesis inhibitor | 0.114 0.071 CID_59215182 | CID_59215182 | |
| 0.037 | 0.243 | 0.104 | Prolactin inhibitor | 0.104 0.052 CID_59215182 | CID_59215182 | |
| 0.045 | 0.255 | 0.115 | Lipid peroxidase inhibitor | 0.115 0.099 CID_59215182 | CID_59215182 | |
| 0.083 | 0.295 | 0.194 | Antioxidant | 0.194 0.119 CID_59215182 | CID_59215182 | |
| 0.039 | 0.262 | 0.097 | GABA C receptor antagonist | 0.097 0.082 CID_59215182 | CID_59215182 | |
| 0.02 | 0.253 | 0.07 | Sphingosine kinase 2 inhibitor | 0.07 0.022 CID_59215182 | CID_59215182 | |
| 0.05 | 0.289 | 0.128 | Toll-Like receptor antagonist | 0.128 0.074 CID_59215182 | CID_59215182 | |
| 0.15 | 0.392 | 0.305 | Calcium channel L-type activator | 0.305 0.153 CID_59215182 | CID_59215182 | |
| 0.018 | 0.272 | 0.088 | Monophenol monooxygenase inhibitor | 0.088 0.085 CID_59215182 | CID_59215182 | |
| 0.036 | 0.31 | 0.101 | Bile acid receptor antagonist | 0.101 0.046 CID_59215182 | CID_59215182 | |
| 0.069 | 0.347 | 0.135 | Interferon gamma antagonist | 0.135 0.101 CID_59215182 | CID_59215182 | |
| 0.006 | 0.288 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.049 CID_59215182 | CID_59215182 | |
| 0.049 | 0.343 | 0.146 | Farnesoid X receptor antagonist | 0.146 0.057 CID_59215182 | CID_59215182 | |
| 0.11 | 0.407 | 0.224 | Tyrosine 3 hydroxylase inhibitor | 0.224 0.098 CID_59215182 | CID_59215182 | |
| 0.053 | 0.365 | 0.183 | Free radical scavenger | 0.183 0.111 CID_59215182 | CID_59215182 | |
| 0.062 | 0.387 | 0.138 | CF transmembrane conductance regulator agonist | 0.138 0.099 CID_59215182 | CID_59215182 | |
| 0.022 | 0.402 | 0.087 | Creatine kinase inhibitor | 0.087 0.076 CID_59215182 | CID_59215182 | |
| 0.105 | 0.517 | 0.323 | Antiinflammatory | 0.323 0.194 CID_59215182 | CID_59215182 | |
| 0.042 | 0.456 | 0.205 | Interleukin agonist | 0.205 0.116 CID_59215182 | CID_59215182 | |
| 0.056 | 0.476 | 0.167 | Superoxide dismutase inhibitor | 0.167 0.16 CID_59215182 | CID_59215182 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |